CDKN2A and pachyonychia congenita: Interestingly, the network and pathway analysis of identified miRNAs and proteins highlighted their involvement in key biological processes related to PC development and progression, which are closely associated with oncogenic driver alterations that mainly affect the KRAS, TP53, CDKN2A, and SMAD4 genes [67].